Collectively, our results demonstrated that CK2α activation by HFD serves as a trigger for mitochondrial damage, hepatic injury, and pathogenesis of MASLD through FUNDC1 disruption and ferroptosis. Here, FUNDC1 is linked to metabolic dysfunction-associated steatotic liver disease.